Additional file 5 of Comprehensive pharmacogenomic characterization of gastric cancer

Additional file 5: Figure S1. Unsupervised clustering of gastric cancers. Figure S2. Frequency of major gastric cancer-driver gene alterations. Figure S3. Pharmacological landscape of gastric cancers for 60 molecular-targeted compounds. Figure S4. Subgroup-specific drug sensitivity among gastric can...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Sa, Jason, Hong, Jung, In-Kyoung Lee, Ju-Sun Kim, Moon-Hee Sim, Kim, Ha, An, Ji, Sohn, Tae, Lee, Joon, Bae, Jae, Kim, Sung, Kyoung-Mee Kim, Kim, Seung, Park, Se, Park, Joon, Lim, Ho, Kang, Won, Nam-Gu Her, Yeri Lee, Cho, Hee, Shin, Yong, Misuk Kim, Harim Koo, Mirinae Kim, Seo, Yun, Kim, Ja, Min-Gew Choi, Do-Hyun Nam, Jeeyun Lee
Format:	Video
Sprache:	eng
Schlagworte:	Biochemistry Biological Sciences not elsewhere classified Cancer Chemical Sciences not elsewhere classified FOS: Biological sciences FOS: Chemical sciences FOS: Health sciences Genetics Infectious Diseases Medicine Molecular Biology Pharmacology
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Additional file 5: Figure S1. Unsupervised clustering of gastric cancers. Figure S2. Frequency of major gastric cancer-driver gene alterations. Figure S3. Pharmacological landscape of gastric cancers for 60 molecular-targeted compounds. Figure S4. Subgroup-specific drug sensitivity among gastric cancers. Figure S5. Gene-drug associations among gastric cancers. Figure S6. Pathway enrichment analysis between ALK-mutant and ALK wild-type tumors. Figure S7. Pharmacological effects of PIK3CA mutations on AZD5363 and Taxol combination treatment. Figure S8. Correlations between RNF11 mRNA expression level and EGFR inhibitors. Figure S9. siRNA-mediated knockdown of RNF11 promotes therapeutic sensitivity to gefitinib.
DOI:	10.6084/m9.figshare.11870445